Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system
- DOI
- 10.1016/j.ebiom.2026.106275
- Published
- 2026-06
- Container
- eBioMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2026.106275,
title = {Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system},
author = {Lusi Zhang and Anthony J. Tholkes and Kathryn R. Cullen and Meredith L. Gunlicks-Stoessel and Pawel Mroz and Joel F. Farley and Steven G. Johnson and Jeffrey R. Bishop},
year = {2026},
journal = {eBioMedicine},
doi = {10.1016/j.ebiom.2026.106275},
url = {https://doi.org/10.1016/j.ebiom.2026.106275}
}RIS
TY - JOUR TI - Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system AU - Lusi Zhang AU - Anthony J. Tholkes AU - Kathryn R. Cullen AU - Meredith L. Gunlicks-Stoessel AU - Pawel Mroz AU - Joel F. Farley AU - Steven G. Johnson AU - Jeffrey R. Bishop PY - 2026 JO - eBioMedicine DO - 10.1016/j.ebiom.2026.106275 UR - https://doi.org/10.1016/j.ebiom.2026.106275 ER -
APA
Zhang, L., Tholkes, A. J., Cullen, K. R., Gunlicks-Stoessel, M. L., Mroz, P., Farley, J. F., Johnson, S. G., & Bishop, J. R. (2026). Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system. eBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106275
Source records
- crossref · retrieved 2026-09-27T10:28:47.157Z